comparemela.com

Latest Breaking News On - Dual path platform - Page 1 : comparemela.com

CDC Laboratory Recommendations for Syphilis Testing, United States, 2024

This report provides new CDC recommendations for tests that can support a diagnosis of syphilis.

United statesUniversity of california san franciscoSan franciscoLos angeles countyGaila bolanJohnr pappYetunde fakileClara pereiraAllan pillayHuman servicesAssociation of public health laboratoriesClinical prevention training centersUs departmentSyphilis health check diagnosticsOffice of managementSyphilis serologic laboratory testing terminology

Chembio Diagnostics, Inc (CEMI) Q3 2022 Earnings Call Transcript

Chembio Diagnostics, Inc. (NASDAQ:NASDAQ:CEMI) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Philip Taylor - Investor Relations Rick Eberly - President.

Sao pauloEstado do rioUnited statesLong islandUnited kingdomRepublic ofLarry steenvoordenRick eberlyPhilip taylorCompany participantsCenters for diseaseReszon diagnostics internationalMinistry of healthGlobal competitiveness programGlobal fundMinistry of health or bio manguinhos

Chembio Diagnostics Reports Third Quarter 2022 Financial Results

Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today

United statesUnited kingdomRichard eberlyPhilip taylorCompany nasdaqReszon diagnostics internationalGlobal competitiveness programAntigen panelExchange commissionChembio diagnostics incGilmartin groupDual path platformSyphilis treponemal nontreponemalSure checkChembio malaysiaChief executive

Jenoptik Breaks Ground on Dresden Fab: Week in Brief: 09/09/2022 | Business | Sep 2022

II-VI announced its corporate name change. The company, which finalized its acquisition of Coherent Inc. this summer, is now called Coherent Corp. The

Soult ukpyolsiSouth koreaUnited statesCity ofUnited kingdomFrance generalJoseph pankertTom darrasBruno desruelleKevin mahaffeyAccurion gmbScintil photonicsSilicon valley bankArmonica technologies incIndustrial technology investment corpAlter technology

Chembio Diagnostics Receives $3 2M From CDC to Develop Syphilis Test

The rapid assay is intended to simultaneously and separately detect treponemal and nontreponemal IgM and IgG antibodies.

Us centers for diseaseDrug administrationChembio diagnosticsDisease controlDual path platformNew york based chembioSyphilis assay

vimarsana © 2020. All Rights Reserved.